Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children is a research paper published in New England Journal of Medicine (2024). On theSindex it has a DataRank of 3.0. It has been cited 188 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.786
From this paper's citation signal
Citation Network Contribution
2.2
From 66 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Cancer Institute
Grant: U10CA180899
National Cancer Institute
Grant: U20CA180886
NCI NIH HHS
Grant: U24 CA196173
NCI NIH HHS
Grant: U10 CA180886
St. Baldrick’s Foundation
FWCI
79.82
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords